104 related articles for article (PubMed ID: 7553586)
1. Expression of the ROS1 oncogene for tyrosine receptor kinase in adult human meningiomas.
Zhao JF; Sharma S
Cancer Genet Cytogenet; 1995 Sep; 83(2):148-54. PubMed ID: 7553586
[TBL] [Abstract][Full Text] [Related]
2. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
[TBL] [Abstract][Full Text] [Related]
3. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.
Carroll RS; Schrell UM; Zhang J; Dashner K; Nomikos P; Fahlbusch R; Black PM
Neurosurgery; 1996 Feb; 38(2):367-75. PubMed ID: 8869066
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.
Pykett MJ; Landers J; George DL
J Neurooncol; 1997 Mar; 32(1):39-44. PubMed ID: 9049861
[TBL] [Abstract][Full Text] [Related]
6. The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas.
Jacobs HM; van Spriel AB; Koehorst SG; Thijssen JH; Blaauw G; Blankenstein MA
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):167-72. PubMed ID: 10704905
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
8. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products.
Maxwell M; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN
Int J Cancer; 1990 Jul; 46(1):16-21. PubMed ID: 2163990
[TBL] [Abstract][Full Text] [Related]
9. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
10. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
[TBL] [Abstract][Full Text] [Related]
12. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptors alpha and beta in human meningiomas.
Carroll RS; Zhang J; Black PM
J Neurooncol; 1999 Apr; 42(2):109-16. PubMed ID: 10421067
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
15. Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?
Fukami S; Riemenschneider MJ; Kohno M; Steiger HJ
Brain Tumor Pathol; 2016 Jul; 33(3):191-9. PubMed ID: 26942600
[TBL] [Abstract][Full Text] [Related]
16. Expression of androgen and progesterone receptors in primary human meningiomas.
Maxwell M; Galanopoulos T; Neville-Golden J; Antoniades HN
J Neurosurg; 1993 Mar; 78(3):456-62. PubMed ID: 8433149
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
Bie L; Zhao G; Ju Y; Zhang B
Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
[TBL] [Abstract][Full Text] [Related]
18. Expression of the JAK and STAT superfamilies in human meningiomas.
Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E
J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819
[TBL] [Abstract][Full Text] [Related]
19. Correlation of proto-oncogene expression and proliferation and meningiomas.
Detta A; Kenny BG; Smith C; Logan A; Hitchcock E
Neurosurgery; 1993 Dec; 33(6):1065-74. PubMed ID: 8133992
[TBL] [Abstract][Full Text] [Related]
20. Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas.
Saini M; Jha AN; Abrari A; Ali S
BMC Cancer; 2012 Jun; 12():212. PubMed ID: 22672386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
